239 related articles for article (PubMed ID: 7783126)
41. Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site.
Mokrosz JL; Bojarski AJ; Maćkowiak M; Bielecka Z; Boksa J
Pharmazie; 1994 May; 49(5):328-33. PubMed ID: 8016178
[TBL] [Abstract][Full Text] [Related]
42. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
43. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
Iben LG; Mahle CD; Yocca FD
Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
[TBL] [Abstract][Full Text] [Related]
44. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
Höök BB; Cortizo L; Johansson AM; Westlind-Danielsson A; Mohell N; Hacksell U
J Med Chem; 1996 Sep; 39(20):4036-43. PubMed ID: 8831769
[TBL] [Abstract][Full Text] [Related]
45. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV
J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570
[TBL] [Abstract][Full Text] [Related]
47. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
Kuipers W; Van Wijngaarden I; Ijzerman AP
Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
[TBL] [Abstract][Full Text] [Related]
48. Binding thermodynamics of 5-HT1A receptor ligands.
Dalpiaz A; Borea PA; Gessi S; Gilli G
Eur J Pharmacol; 1996 Sep; 312(1):107-14. PubMed ID: 8891585
[TBL] [Abstract][Full Text] [Related]
49. Introduction of a methyl group in alpha- or beta-position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties.
Roglic G; Andric D; Kostic-Rajacic S; Dukic S; Soskic V
Arch Pharm (Weinheim); 2001 Dec; 334(12):375-80. PubMed ID: 11852532
[TBL] [Abstract][Full Text] [Related]
50. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.
Chilmonczyk Z; Cybulski M; Iskra-Jopa J; Chojnacka-Wójcik E; Tatarczyńska E; Kłodzińska A; Leś A; Bronowska A; Sylte I
Farmaco; 2002 Apr; 57(4):285-301. PubMed ID: 11989808
[TBL] [Abstract][Full Text] [Related]
51. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
53. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
[TBL] [Abstract][Full Text] [Related]
54. Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.
Chilmonczyk Z; Szelejewska-Wozniakowska A; Cybulski J; Cybulski M; Koziol AE; Gdaniec M
Arch Pharm (Weinheim); 1997 May; 330(5):146-60. PubMed ID: 9237427
[TBL] [Abstract][Full Text] [Related]
55. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
56. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
[TBL] [Abstract][Full Text] [Related]
57. Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study.
Glennon RA; Ismaiel AE; McCarthy BG; Peroutka SJ
Eur J Pharmacol; 1989 Sep; 168(3):387-92. PubMed ID: 2583244
[TBL] [Abstract][Full Text] [Related]
58. Bioactive conformation of 1-arylpiperazines at central serotonin receptors.
Huff JR; King SW; Saari WS; Springer JP; Martin GE; Williams M
J Med Chem; 1985 Jul; 28(7):945-8. PubMed ID: 4009617
[TBL] [Abstract][Full Text] [Related]
59. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
Paluchowska MH; Kłodzińska A; Tatarczyńska E; Szaro A; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
